Macquarie Group’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-550,018
Closed -$15.2M 1667
2024
Q3
$15.2M Buy
+550,018
New +$13.8M 0.02% 746
2022
Q3
Sell
-345
Closed -$4.18K 2478
2022
Q2
$3K Sell
345
-28,935
-99% -$584K ﹤0.01% 2547
2022
Q1
$1.01K Buy
29,280
+28,106
+2,394% +$912K ﹤0.01% 1549
2021
Q4
$58K Buy
1,174
+102
+10% +$5.38K ﹤0.01% 2109
2021
Q3
$49K Sell
1,072
-367
-26% -$14.5K ﹤0.01% 2239
2021
Q2
$43K Buy
1,439
+387
+37% +$7.9K ﹤0.01% 2187
2021
Q1
$21K Buy
+1,052
New +$22.2K ﹤0.01% 2262
2020
Q2
Sell
-5,490
Closed -$34K 2359
2020
Q1
$34K Buy
+5,490
New +$44.6K ﹤0.01% 1855
2018
Q1
Sell
-6,401
Closed -$31K 2174
2017
Q4
$31K Buy
+6,401
New +$29.8K ﹤0.01% 2133

Other funds holding ASPN

Macquarie Group's ASPN Position: Q4 2024 in Review

Macquarie Group sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 550,018 shares — an estimated $15.2M sold.

Macquarie Group first reported a position in ASPN in Q4 2017 and held it in 9 quarters. The position peaked at $15.2M in Q3 2024. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • Macquarie Group reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • Macquarie Group sold 550,018 Aspen Aerogels shares in Q4 2024, an estimated $15.2M.
  • Macquarie Group first reported a position in Aspen Aerogels in Q4 2017 and held it in 9 quarters.
  • Macquarie Group's Aspen Aerogels position peaked at $15.2M in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on Macquarie Group's 13F filing for Q4 2024, filed 14 Feb 2025.